Browse by Nurse Practitioner Items
Nurse practitioner PBS prescribing
MEDICINES WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS
From 1 September 2010, nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners). Information for nurse practitioners to become authorised PBS prescribers is available from Services Australia.
The medicines listed for prescribing by authorised nurse practitioners from 1 November 2010 are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not write PBS prescriptions for other medicines.
PBS prescribing is limited by a nurse practitioner’s scope of practice, and state and territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner and having collaborative arrangements in place, as required by amendments to the National Health Act 1953.
The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health regarding medicines for prescribing by authorised nurse practitioners.
Further to prescribing within collaborative arrangements, certain medicines also have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. These medicines are identified by the codes ‘CTO’ for continuation therapy only or ‘SCM’ for prescribing within a shared care model, as outlined below:
- Continuing therapy only model
Where the patient’s treatment and prescribing of a medicine has been initiated by a medical practitioner, but prescribing is continued by a nurse practitioner. (This is similar to existing arrangements between specialists and medical practitioners for prescribing certain medicines.)
- Shared care model
Where care is shared between a nurse practitioner and medical practitioner in a formalised arrangement with an agreed plan to manage the patient, in a patientcentred model of care. The details surrounding shared care arrangements will depend on the practitioners involved, patient needs and the healthcare context.
Some medicines are included in more than one section of the Schedule, and for more than one prescriber type. For a prescription to be eligible for subsidy, prescribers must ensure that they prescribe under the PBS only those medicines, and in accordance with the restrictions, listed for their prescriber type. Listing details for the same product may differ between sections and different PBS item codes apply for each prescriber type.
Nurse practitioner PBS prescriptions are identifiable by colour, and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms.
Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, midwives/nurse practitioners can use the personalised or non-personalised PBS prescriber forms. For authority required and authority required (streamlined) PBS medicines, midwives/nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms. Nurse practitioner PBS prescriptions may include repeats.
Regulation 49 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.
Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from Services Australia for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying medicines — What Pharmacists Need to Know, for more information on authority prescriptions.)
State and territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.
- Legend
- PPalliative care items
- MPMedical Practitioner
- NPNurse Practitioner
-
SO
Products that are in a Supply Only state will be available for dispensing, but not for prescribing. PBS Prescriptions written prior to the Supply Only period are able to be dispensed using either the Supply Only product where available, or an equivalent product as specified on the PBS schedule.
- 60D60-day prescriptions
Prescriber code | Item code | Name, manner of administration and form & strength | Max qty packs |
Max qty units |
No. of repeats |
---|---|---|---|---|---|
MPNP | 10911G | TAMOXIFENtamoxifen 20 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 13906X | TAMOXIFENtamoxifen 20 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 1880Y | TAMOXIFENtamoxifen 20 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 13960R | TAMOXIFENtamoxifen 20 mg tablet, 30 | 4 | 120 | 5 |
MPNP | 13997Q | TAMOXIFENtamoxifen 20 mg tablet, 60 | 2 | 120 | 5 |
MPNP | 2110C | TAMOXIFENtamoxifen 20 mg tablet, 60 | 1 | 60 | 5 |
MPNP | 10094G | TAPENTADOLtapentadol 100 mg modified release tablet, 28 | 1 | 28 | 0 |
MPNP | 10100N | TAPENTADOLtapentadol 150 mg modified release tablet, 28 | 1 | 28 | 0 |
MPNP | 10091D | TAPENTADOLtapentadol 200 mg modified release tablet, 28 | 1 | 28 | 0 |
MPNP | 10092E | TAPENTADOLtapentadol 250 mg modified release tablet, 28 | 1 | 28 | 0 |
MPNP | 10096J | TAPENTADOLtapentadol 50 mg modified release tablet, 28 | 1 | 28 | 0 |
MPNP | 13437F | TELMISARTANtelmisartan 40 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 8355R | TELMISARTANtelmisartan 40 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 13593K | TELMISARTANtelmisartan 80 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 8356T | TELMISARTANtelmisartan 80 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 13515H | TELMISARTAN + AMLODIPINEtelmisartan 40 mg + amlodipine 10 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 8979N | TELMISARTAN + AMLODIPINEtelmisartan 40 mg + amlodipine 10 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 13483P | TELMISARTAN + AMLODIPINEtelmisartan 40 mg + amlodipine 5 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 8978M | TELMISARTAN + AMLODIPINEtelmisartan 40 mg + amlodipine 5 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 13451Y | TELMISARTAN + AMLODIPINEtelmisartan 80 mg + amlodipine 10 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 8981Q | TELMISARTAN + AMLODIPINEtelmisartan 80 mg + amlodipine 10 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 13450X | TELMISARTAN + AMLODIPINEtelmisartan 80 mg + amlodipine 5 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 8980P | TELMISARTAN + AMLODIPINEtelmisartan 80 mg + amlodipine 5 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 13546Y | TELMISARTAN + HYDROCHLOROTHIAZIDEtelmisartan 40 mg + hydrochlorothiazide 12.5 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 8622T | TELMISARTAN + HYDROCHLOROTHIAZIDEtelmisartan 40 mg + hydrochlorothiazide 12.5 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 13574K | TELMISARTAN + HYDROCHLOROTHIAZIDEtelmisartan 80 mg + hydrochlorothiazide 12.5 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 8623W | TELMISARTAN + HYDROCHLOROTHIAZIDEtelmisartan 80 mg + hydrochlorothiazide 12.5 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 13607E | TELMISARTAN + HYDROCHLOROTHIAZIDEtelmisartan 80 mg + hydrochlorothiazide 25 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 9381R | TELMISARTAN + HYDROCHLOROTHIAZIDEtelmisartan 80 mg + hydrochlorothiazide 25 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 2088X | TEMAZEPAMtemazepam 10 mg tablet, 25 | 2 | 50 | 5 |
MPNP | 2089Y | TEMAZEPAMtemazepam 10 mg tablet, 25 | 1 | 25 | 0 |
MPNP | 5375X | TEMAZEPAMtemazepam 10 mg tablet, 25 | 2 | 50 | 3 |
MPNP | 8526R | TENECTEPLASEtenecteplase 40 mg injection [1 vial] (&) inert substance diluent [8 mL syringe], 1 pack | 1 | 1 | 0 |
MPNP | 13128Y | TENECTEPLASEtenecteplase 50 mg injection [1 vial] (&) inert substance diluent [10 mL syringe], 1 pack | 1 | 1 | 0 |
MPNP | 8527T | TENECTEPLASEtenecteplase 50 mg injection [1 vial] (&) inert substance diluent [10 mL syringe], 1 pack | 1 | 1 | 0 |
MPNP | 11114Y | TENOFOVIR ALAFENAMIDE + EMTRICITABINE + ELVITEGRAVIR + COBICISTATtenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 10310P | TENOFOVIR DISOPROXILtenofovir disoproxil fumarate 300 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 11992E | TENOFOVIR DISOPROXILtenofovir disoproxil fumarate 300 mg tablet, 30 | 2 | 60 | 2 |
MPNP | 11142K | TENOFOVIR DISOPROXILtenofovir disoproxil phosphate 291 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 11978K | TENOFOVIR DISOPROXILtenofovir disoproxil phosphate 291 mg tablet, 30 | 2 | 60 | 2 |
MPNP | 11155D | TENOFOVIR DISOPROXILtenofovir disoproxil maleate 300 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 11982P | TENOFOVIR DISOPROXILtenofovir disoproxil maleate 300 mg tablet, 30 | 2 | 60 | 2 |
MPNP | 12506F | TENOFOVIR DISOPROXIL + EMTRICITABINEtenofovir disoproxil succinate 301 mg + emtricitabine 200 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 12542D | TENOFOVIR DISOPROXIL + EMTRICITABINEtenofovir disoproxil succinate 301 mg + emtricitabine 200 mg tablet, 30 | 1 | 30 | 2 |
MPNP | 11146P | TENOFOVIR DISOPROXIL + EMTRICITABINEtenofovir disoproxil phosphate 291 mg + emtricitabine 200 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 11306C | TENOFOVIR DISOPROXIL + EMTRICITABINEtenofovir disoproxil phosphate 291 mg + emtricitabine 200 mg tablet, 30 | 1 | 30 | 2 |
MPNP | 11149T | TENOFOVIR DISOPROXIL + EMTRICITABINEtenofovir disoproxil maleate 300 mg + emtricitabine 200 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 11296M | TENOFOVIR DISOPROXIL + EMTRICITABINEtenofovir disoproxil maleate 300 mg + emtricitabine 200 mg tablet, 30 | 1 | 30 | 2 |
MPNP | 10347N | TENOFOVIR DISOPROXIL + EMTRICITABINEtenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 11276L | TENOFOVIR DISOPROXIL + EMTRICITABINEtenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 | 1 | 30 | 2 |
MPNP | 11732L | TENOFOVIR DISOPROXIL + EMTRICITABINE + EFAVIRENZtenofovir disoproxil maleate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 9160D | TERBINAFINEterbinafine hydrochloride 1% cream, 15 g | 2 | 2 | 3 |
MPNP | 2285G | TERBINAFINEterbinafine 250 mg tablet, 42 | 1 | 42 | 0 |
MPNP | 2804N | TERBINAFINEterbinafine 250 mg tablet, 42 | 1 | 42 | 1 |
MPNP | 12267P | TERBUTALINEterbutaline sulfate 500 microgram/actuation powder for inhalation, 120 actuations | 2 | 2 | 5 |
MPNP | 1034K | TERBUTALINEterbutaline sulfate 500 microgram/mL injection, 5 x 1 mL ampoules | 1 | 5 | 0 |
MPNP | 1330B | TETRABENAZINEtetrabenazine 25 mg tablet, 112 | 1 | 112 | 5 |
MPNP | 14390J | TETRABENAZINEtetrabenazine 25 mg tablet, 112 | 2 | 224 | 5 |
MPNP | 2614N | THEOPHYLLINEtheophylline 133.3 mg/25 mL oral liquid, 500 mL | 1 | 1 | 5 |
MPNP | 8230E | THEOPHYLLINEtheophylline 200 mg modified release tablet, 100 | 1 | 100 | 5 |
MPNP | 2634P | THEOPHYLLINEtheophylline 250 mg modified release tablet, 100 | 1 | 100 | 5 |
MPNP | 8231F | THEOPHYLLINEtheophylline 300 mg modified release tablet, 100 | 1 | 100 | 5 |
MPNP | 1070H | THIAMINEthiamine hydrochloride 100 mg tablet, 100 | 1 | 100 | 2 |
MPNP | 13354W | THIAMINEthiamine hydrochloride 100 mg tablet, 100 | 2 | 200 | 2 |
MPNP | 13947C | TIAGABINEtiagabine 10 mg tablet, 50 | 4 | 200 | 5 |
MPNP | 8222R | TIAGABINEtiagabine 10 mg tablet, 50 | 2 | 100 | 5 |
MPNP | 13893F | TIAGABINEtiagabine 15 mg tablet, 50 | 4 | 200 | 5 |
MPNP | 8223T | TIAGABINEtiagabine 15 mg tablet, 50 | 2 | 100 | 5 |
MPNP | 13892E | TIAGABINEtiagabine 5 mg tablet, 50 | 4 | 200 | 5 |
MPNP | 8221Q | TIAGABINEtiagabine 5 mg tablet, 50 | 2 | 100 | 5 |
MPNP | 13524T | TICAGRELORticagrelor 90 mg tablet, 56 | 2 | 112 | 5 |
MPNP | 1418P | TICAGRELORticagrelor 90 mg tablet, 56 | 1 | 56 | 5 |
MPNP | 11892X | TIOTROPIUMtiotropium 13 microgram powder for inhalation, 30 capsules | 1 | 30 | 5 |
MPNP | 14555C | TIOTROPIUMtiotropium 13 microgram powder for inhalation, 30 capsules | 2 | 60 | 5 |
MPNP | 14361W | TIOTROPIUMtiotropium 18 microgram powder for inhalation, 30 capsules | 2 | 60 | 5 |
MPNP | 14574C | TIOTROPIUMtiotropium 18 microgram powder for inhalation, 30 capsules | 2 | 60 | 5 |
MPNP | 14576E | TIOTROPIUMtiotropium 18 microgram powder for inhalation, 30 capsules | 1 | 30 | 5 |
MPNP | 8626B | TIOTROPIUMtiotropium 18 microgram powder for inhalation, 30 capsules | 1 | 30 | 5 |
MPNP | 10509D | TIOTROPIUMtiotropium 2.5 microgram/actuation inhalation solution, 60 actuations | 1 | 1 | 5 |
MPNP | 11043F | TIOTROPIUMtiotropium 2.5 microgram/actuation inhalation solution, 60 actuations | 1 | 1 | 5 |
MPNP | 11629C | TIOTROPIUMtiotropium 2.5 microgram/actuation inhalation solution, 60 actuations | 1 | 1 | 5 |
MPNP | 14323W | TIOTROPIUMtiotropium 2.5 microgram/actuation inhalation solution, 60 actuations | 2 | 2 | 5 |
MPNP | 14499D | TIOTROPIUMtiotropium 2.5 microgram/actuation inhalation solution, 60 actuations | 2 | 2 | 5 |
MPNP | 14531T | TIOTROPIUMtiotropium 2.5 microgram/actuation inhalation solution, 60 actuations | 2 | 2 | 5 |
MPNP | 10557P | TIOTROPIUM + OLODATEROLtiotropium 2.5 microgram/actuation + olodaterol 2.5 microgram/actuation inhalation solution, 60 actuations | 1 | 1 | 5 |
MPNP | 14530R | TIOTROPIUM + OLODATEROLtiotropium 2.5 microgram/actuation + olodaterol 2.5 microgram/actuation inhalation solution, 60 actuations | 2 | 2 | 5 |
MPNP | 8350L | TIROFIBANtirofiban 12.5 mg/50 mL injection, 50 mL vial | 1 | 1 | 2 |
MPNP | 9480Y | TOBRAMYCINtobramycin 500 mg/5 mL injection, 10 x 5 mL vials | 1 | 10 | 1 |
MPNP | 1356J | TOBRAMYCINtobramycin 80 mg/2 mL injection, 5 x 2 mL vials | 2 | 10 | 1 |
MPNP | 8872Y | TOBRAMYCINtobramycin Injection 80 mg (base) in 2 mL (without preservative), 5 | 2 | 10 | 1 |
MPNP | 14008G | TOPIRAMATEtopiramate 100 mg tablet, 60 | 2 | 120 | 5 |
MPNP | 8165R | TOPIRAMATEtopiramate 100 mg tablet, 60 | 1 | 60 | 5 |
MPNP | 14009H | TOPIRAMATEtopiramate 200 mg tablet, 60 | 2 | 120 | 5 |
MPNP | 8166T | TOPIRAMATEtopiramate 200 mg tablet, 60 | 1 | 60 | 5 |
MPNP | 13969F | TOPIRAMATEtopiramate 25 mg tablet, 60 | 2 | 120 | 5 |
MPNP | 8163P | TOPIRAMATEtopiramate 25 mg tablet, 60 | 1 | 60 | 5 |
MPNP | 13913G | TOPIRAMATEtopiramate 50 mg tablet, 60 | 2 | 120 | 5 |
MPNP | 8164Q | TOPIRAMATEtopiramate 50 mg tablet, 60 | 1 | 60 | 5 |
MPNP | 14063E | TOPIRAMATEtopiramate 15 mg capsule, 60 | 2 | 120 | 5 |
MPNP | 8371N | TOPIRAMATEtopiramate 15 mg capsule, 60 | 1 | 60 | 5 |
MPNP | 13905W | TOPIRAMATEtopiramate 25 mg capsule, 60 | 2 | 120 | 5 |
MPNP | 8372P | TOPIRAMATEtopiramate 25 mg capsule, 60 | 1 | 60 | 5 |
MPNP | 13878K | TOPIRAMATEtopiramate 50 mg capsule, 60 | 2 | 120 | 5 |
MPNP | 8520K | TOPIRAMATEtopiramate 50 mg capsule, 60 | 1 | 60 | 5 |
MPNP | 2527B | TRAMADOLtramadol hydrochloride 50 mg modified release tablet, 20 | 1 | 20 | 0 |
MPNP | 12008B | TRAMADOLtramadol hydrochloride 50 mg capsule, 20 | 0.5 | 10 | 0 |
MPNP | 8455B | TRAMADOLtramadol hydrochloride 50 mg capsule, 20 | 1 | 20 | 0 |
MPNP | 3484J | TRAMADOLtramadol hydrochloride 100 mg/2 mL injection, 5 x 2 mL ampoules | 1 | 5 | 0 |
MPNP | 8582Q | TRAMADOLtramadol hydrochloride 100 mg/2 mL injection, 5 x 2 mL ampoules | 1 | 5 | 0 |
MPNP | 8843K | TRAMADOLtramadol hydrochloride 100 mg/mL oral liquid, 10 mL | 1 | 1 | 0 |
MPNP | 8523N | TRAMADOLtramadol hydrochloride 100 mg modified release tablet, 20 | 1 | 20 | 0 |
MPNP | 8524P | TRAMADOLtramadol hydrochloride 150 mg modified release tablet, 20 | 1 | 20 | 0 |
MPNP | 8525Q | TRAMADOLtramadol hydrochloride 200 mg modified release tablet, 20 | 1 | 20 | 0 |
MPNP | 13429T | TRANDOLAPRILtrandolapril 1 mg capsule, 28 | 2 | 56 | 5 |
MPNP | 2792Y | TRANDOLAPRILtrandolapril 1 mg capsule, 28 | 1 | 28 | 5 |
MPNP | 13403K | TRANDOLAPRILtrandolapril 2 mg capsule, 28 | 2 | 56 | 5 |
MPNP | 2793B | TRANDOLAPRILtrandolapril 2 mg capsule, 28 | 1 | 28 | 5 |
MPNP | 13467T | TRANDOLAPRILtrandolapril 4 mg capsule, 28 | 2 | 56 | 5 |
MPNP | 8758Y | TRANDOLAPRILtrandolapril 4 mg capsule, 28 | 1 | 28 | 5 |
MPNP | 13554J | TRANDOLAPRILtrandolapril 500 microgram capsule, 28 | 2 | 56 | 5 |
MPNP | 2791X | TRANDOLAPRILtrandolapril 500 microgram capsule, 28 | 1 | 28 | 5 |
MPNP | 13594L | TRANDOLAPRIL + VERAPAMILtrandolapril 2 mg + verapamil hydrochloride 180 mg modified release tablet, 28 | 2 | 56 | 5 |
MPNP | 9387C | TRANDOLAPRIL + VERAPAMILtrandolapril 2 mg + verapamil hydrochloride 180 mg modified release tablet, 28 | 1 | 28 | 5 |
MPNP | 13591H | TRANDOLAPRIL + VERAPAMILtrandolapril 4 mg + verapamil hydrochloride 240 mg modified release tablet, 28 | 2 | 56 | 5 |
MPNP | 2857J | TRANDOLAPRIL + VERAPAMILtrandolapril 4 mg + verapamil hydrochloride 240 mg modified release tablet, 28 | 1 | 28 | 5 |
MPNP | 2180R | TRANEXAMIC ACIDtranexamic acid 500 mg tablet, 100 | 1 | 100 | 2 |
MPNP | 2117K | TRIAMCINOLONEtriamcinolone acetonide 0.02% cream, 100 g | 2 | 2 | 0 |
MPNP | 2990J | TRIAMCINOLONEtriamcinolone acetonide 10 mg/mL injection, 5 x 1 mL ampoules | 1 | 5 | 0 |
MPNP | 2118L | TRIAMCINOLONEtriamcinolone acetonide 0.02% ointment, 100 g | 2 | 2 | 0 |
MPNP | 2971J | TRIAMCINOLONE + NEOMYCIN + GRAMICIDIN + NYSTATINtriamcinolone acetonide 0.09% + neomycin 0.225% + gramicidin 0.0225% + nystatin 90 000 units/mL ear drops, 7.5 mL | 1 | 1 | 2 |
MPNP | 2974M | TRIAMCINOLONE + NEOMYCIN + GRAMICIDIN + NYSTATINtriamcinolone acetonide 0.1% + neomycin 0.25% + gramicidin 0.025% + nystatin 100 000 units/g ointment, 5 g | 1 | 1 | 2 |
MPNP | 13124R | TRIENTINEtrientine dihydrochloride 250 mg capsule, 100 | 2 | 200 | 5 |
MPNP | 9308X | TRIGLYCERIDES LONG CHAIN WITH GLUCOSE POLYMERtriglycerides long chain with glucose polymer oral liquid, 18 x 250 mL cartons | 6 | 6 | 5 |
MPNP | 10189G | TRIGLYCERIDES LONG CHAIN WITH GLUCOSE POLYMERtriglycerides long chain with glucose polymer oral liquid, 27 x 200 mL cartons | 2 | 2 | 5 |
MPNP | 9309Y | TRIGLYCERIDES LONG CHAIN WITH GLUCOSE POLYMERtriglycerides long chain with glucose polymer oral liquid, 6 x 1 L cartons | 4 | 4 | 5 |
MPNP | 3136C | TRIGLYCERIDES MEDIUM CHAIN AND LONG CHAIN WITH GLUCOSE POLYMERtriglycerides medium chain and long chain with glucose polymer powder for oral liquid, 400 g | 8 | 8 | 5 |
MPNP | 10152H | TRIGLYCERIDES MEDIUM CHAIN FORMULAtriglycerides medium chain formula powder for oral liquid, 400 g | 8 | 8 | 5 |
MPNP | 10154K | TRIGLYCERIDES MEDIUM CHAIN FORMULAtriglycerides medium chain formula powder for oral liquid, 400 g | 8 | 8 | 5 |
MPNP | 10155L | TRIGLYCERIDES MEDIUM CHAIN FORMULAtriglycerides medium chain formula powder for oral liquid, 400 g | 8 | 8 | 5 |
MPNP | 1938B | TRIGLYCERIDES MEDIUM CHAIN FORMULAtriglycerides medium chain formula powder for oral liquid, 400 g | 8 | 8 | 5 |
MPNP | 8478F | TRIGLYCERIDES MEDIUM CHAIN FORMULAtriglycerides medium chain formula powder for oral liquid, 400 g | 8 | 8 | 5 |
MPNP | 12948L | TRIGLYCERIDES MEDIUM CHAIN FORMULAtriglycerides medium chain formula oral liquid, 12 x 500 mL bottles | 12 | 12 | 5 |
MPNP | 1109J | TRIHEXYPHENIDYL (BENZHEXOL)trihexyphenidyl (benzhexol) hydrochloride 2 mg tablet, 200 | 1 | 200 | 2 |
MPNP | 1110K | TRIHEXYPHENIDYL (BENZHEXOL)trihexyphenidyl (benzhexol) hydrochloride 5 mg tablet, 200 | 1 | 200 | 1 |
MPNP | 2922T | TRIMETHOPRIMtrimethoprim 300 mg tablet, 7 | 1 | 7 | 1 |
MPNP | 3103H | TRIMETHOPRIM + SULFAMETHOXAZOLEtrimethoprim 40 mg/5 mL + sulfamethoxazole 200 mg/5 mL oral liquid, 100 mL | 1 | 1 | 1 |
MPNP | 2951H | TRIMETHOPRIM + SULFAMETHOXAZOLEtrimethoprim 160 mg + sulfamethoxazole 800 mg tablet, 10 | 1 | 10 | 1 |
MPNP | 9165J | TYROSINE WITH CARBOHYDRATEtyrosine with carbohydrate containing 1 g tyrosine powder for oral liquid, 30 x 4 g sachets | 4 | 4 | 5 |